Cogent Biosciences Statistics
Total Valuation
COGT has a market cap or net worth of $6.40 billion. The enterprise value is $5.85 billion.
| Market Cap | 6.40B |
| Enterprise Value | 5.85B |
Important Dates
The last earnings date was Monday, August 10, 2026, before market open.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COGT has 173.57 million shares outstanding. The number of shares has increased by 37.58% in one year.
| Current Share Class | 173.52M |
| Shares Outstanding | 173.57M |
| Shares Change (YoY) | +37.58% |
| Shares Change (QoQ) | +5.41% |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 116.43% |
| Float | 172.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 63.20 |
| PB Ratio | 13.53 |
| P/TBV Ratio | 13.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.57, with a Debt / Equity ratio of 0.46.
| Current Ratio | 13.57 |
| Quick Ratio | 13.36 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -75.14 |
Financial Efficiency
Return on equity (ROE) is -109.74% and return on invested capital (ROIC) is -49.01%.
| Return on Equity (ROE) | -109.74% |
| Return on Assets (ROA) | -43.84% |
| Return on Invested Capital (ROIC) | -49.01% |
| Return on Capital Employed (ROCE) | -50.19% |
| Weighted Average Cost of Capital (WACC) | 5.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.46M |
| Employee Count | 258 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +204.29% in the last 52 weeks. The beta is 0.33, so COGT's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +204.29% |
| 50-Day Moving Average | 38.16 |
| 200-Day Moving Average | 36.28 |
| Relative Strength Index (RSI) | 41.12 |
| Average Volume (20 Days) | 1,842,187 |
Short Selling Information
The latest short interest is 17.89 million, so 10.31% of the outstanding shares have been sold short.
| Short Interest | 17.89M |
| Short Previous Month | 16.56M |
| Short % of Shares Out | 10.31% |
| Short % of Float | 10.37% |
| Short Ratio (days to cover) | 7.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -389.09M |
| Pretax Income | -377.18M |
| Net Income | -377.18M |
| EBITDA | -386.46M |
| EBIT | -389.09M |
| Earnings Per Share (EPS) | -$2.43 |
Balance Sheet
The company has $792.30 million in cash and $244.26 million in debt, with a net cash position of $548.04 million or $3.16 per share.
| Cash & Cash Equivalents | 792.30M |
| Total Debt | 244.26M |
| Net Cash | 548.04M |
| Net Cash Per Share | $3.16 |
| Equity (Book Value) | 532.39M |
| Book Value Per Share | 2.72 |
| Working Capital | 745.52M |
Cash Flow
In the last 12 months, operating cash flow was -$307.55 million and capital expenditures -$1.70 million, giving a free cash flow of -$309.24 million.
| Operating Cash Flow | -307.55M |
| Capital Expenditures | -1.70M |
| Depreciation & Amortization | 2.64M |
| Net Borrowing | 168.47M |
| Free Cash Flow | -309.24M |
| FCF Per Share | -$1.78 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COGT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.58% |
| Shareholder Yield | n/a |
| Earnings Yield | -5.90% |
| FCF Yield | -4.83% |
Analyst Forecast
The average price target for COGT is $55.82, which is 51.48% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $55.82 |
| Price Target Difference | 51.48% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 9, 2020. It was a reverse split with a ratio of 1:4.
| Last Split Date | Nov 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |